ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
PhaseBio Pharmaceuticals Inc

PhaseBio Pharmaceuticals Inc (PHAS)

0.0701
0.00
( 0.00% )
Updated: 18:00:00

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.0701
Bid
0.0645
Ask
0.0671
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
0.0701
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

PHAS Latest News

PhaseBio Plans for Near-Term Sale Using Structured Process Through Chapter 11 of U.S. Bankruptcy Code

Bidding Process and Auction Projected to Conclude December 2022 PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and...

PhaseBio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Business Highlights

PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular diseases, today...

PhaseBio Announces Successful Pre-BLA Meeting with U.S. FDA for Bentracimab

PhaseBio recently received formal written minutes from the FDA following its Pre-BLA Meeting held in early April and is expecting to submit its Biologics License Application (BLA) by early in the...

PhaseBio Pharmaceuticals to Participate in the 21st Annual Needham Healthcare Conference

PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular diseases, today...

PhaseBio Announces Positive Results from Phase 2b Trial for Bentracimab

Results presented on April 2nd during a Late Breaking Featured Clinical Research Presentation at the American College of Cardiology’s 71st Annual Scientific Session (ACC.22) Trial achieved...

PhaseBio Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights

Achieved key clinical milestones for bentracimab program, with positive results from both the completed Phase 2b trial and interim analysis of the ongoing REVERSE-IT global Phase 3 trial Company...

PhaseBio Pharmaceuticals Announces Bentracimab Manufacturing Update

Manufacturing of bentracimab drug substance and drug product Process Performance Qualification (PPQ) batches has been completed PhaseBio remains on track to submit bentracimab Biologics License...

PhaseBio Pharmaceuticals to Participate in the Cowen 42nd Annual Health Care Conference

PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular diseases, today...

PhaseBio Announces Bentracimab Phase 2b Trial Data Accepted for Late Breaking Clinical Research Presentation at the 2022 American College of Cardiology (ACC.22) Annual Scientific Session

PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SPPLSIMPPLE Ltd
US$ 0.9706
(203.31%)
327.44M
NUWENewellis Inc
US$ 2.839
(108.75%)
92.86M
STAFStaffing 360 Solutions Inc
US$ 2.8187
(65.81%)
49.32M
ADNAdvent Technologies Holdings Inc
US$ 3.0757
(61.88%)
60.99M
OMICSingular Genomics Systems Inc
US$ 21.55
(60.10%)
288.84k
FIACFocus Impact Acquisition Corporation
US$ 1.00
(-88.74%)
172
TOIIWOncology Institute Inc
US$ 0.0101
(-47.67%)
58.22k
SSPEW Scripps Company
US$ 2.1801
(-38.07%)
3.3M
INVZWInnoviz Technologies Ltd
US$ 0.0642
(-33.13%)
2k
GCTKGlucoTrack Inc
US$ 1.18
(-32.18%)
70.42k
SPPLSIMPPLE Ltd
US$ 0.9706
(203.31%)
327.44M
ELABElevai Labs Inc
US$ 0.0199
(-31.14%)
222.9M
SQQQProShares UltraPro Short QQQ
US$ 7.4501
(0.14%)
135.55M
NVDANVIDIA Corporation
US$ 138.155
(2.03%)
132.13M
PLUGPlug Power Inc
US$ 2.4693
(18.15%)
93.48M

Discussion

View Full Feed
krisrun krisrun 5 minutes ago
(1) Critical disengagement number (after V13) of 680 to xxx number - I just google it and it came up. After V14 (2Q 2025) it will improve more. (2) Presently, I am looking for any Robotaxi startup even with Safety driver> this will be a big news. (3) From long time, I lost lot of hope on TSLA.
TSLA
delerious1 delerious1 5 minutes ago
Thot I smelled something
NBRI
Monksdream Monksdream 5 minutes ago
ANET, 10Q 11/7
https://investorshub.advfn.com/uimage/uploads/2024/11/4/qwianIMG_3060.gif
ANET
sab63090 sab63090 5 minutes ago
The latest information on the Class Action Lawsuit:

was in May 2024 ....still ongoing and surely Investor is monitoring the developments on Court Reporter....damn, I hate legals.
AVXL
Mark Mark 5 minutes ago
$SPPL 1.16 halted up, definitely the "chosen one" today, congrats if your still in it.
SPPL
Trooperstocks Trooperstocks 5 minutes ago
$ILLR Triller will see more users after new TikTok law.
https://www.foxbusiness.com/video/6351757905112
ILLR
Trooperstocks Trooperstocks 6 minutes ago
$ILLR Triller will see more users after new TikTok law.
https://www.foxbusiness.com/video/6351757905112
ILLR
surfkast surfkast 6 minutes ago
Desperate pumpers losing while the PPS is headed back to .0001. Or will this get suspended first?
SPZI
1plus1 1plus1 6 minutes ago
MY POST GOT DELETED
HIRU
KoljaFTW KoljaFTW 6 minutes ago
Scam? Glad i got out
AZRH
dennisdave dennisdave 6 minutes ago
This is nothing to be concerned about, nothing
lol you saying this reminds me of this great meme

https://www.youtube.com/watch?v=axjQvkJnHS8
NWBO
biowin biowin 6 minutes ago
Nice, who signed for Cassels lawyers after it was discussed with Mica Arlette, the pwc insolvency trustee?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146912082
threewheeler threewheeler 7 minutes ago
check the breakout board nothing doing any thing with election tomorrow
BNCM
dexprs dexprs 7 minutes ago
Bought back 5 Puts in NVDA at $1.69/share. Were sold a day ago at $1.99. Waiting until NVDA goes negative to sell them again, perhaps 2x5 options.
NVDA
Infinitygold Infinitygold 7 minutes ago
Expert market looming.......
OSCI
chemist72 chemist72 7 minutes ago
Some lucky dog got 1000 shares RDGL at $.1084 -

That is the lowest price trade I've seen so far today.

Looks like some holders threw in the towel between 13:15 and 13:21. Then 4 or 5 minutes later there was a huge buying surge. About 50% more volume than the sell-off.
RDGL
Catpole Catpole 7 minutes ago
I suspect some big news! History shows major move in PPS as it trades very thin.
APRU
oystersnbeer oystersnbeer 7 minutes ago
Humiliated

https://youtu.be/FuducqLP650
waterchaser waterchaser 8 minutes ago
It's important to educate the less informed...
no matter what side of the pump and dump they are on.
HIRU
Chartmaster Chartmaster 8 minutes ago
I think someone is covering their shorts! Or crapping them! Lol!
NBRI
LORTAP KCOTS LORTAP KCOTS 8 minutes ago
What's your prediction for tomorrow, or post election? This could tank deep if democrats win, I'm not sure if I can stomach holding a trade through the next few days
TSLA
 just Scottie just Scottie 8 minutes ago
I can’t find anyone else doing interviews on the nyse floor other than https://www.nyse.com/insights/floor-talk-with-judy-shaw
RDAR

Your Recent History

Delayed Upgrade Clock